OTCMKTS:RPBC Redpoint Bio (RPBC) Stock Price, News & Analysis $0.0001 +0.00 (+∞) As of 07/23/2019 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Redpoint Bio Stock (OTCMKTS:RPBC) Get Redpoint Bio alerts:Sign Up Key Stats Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.0001▼$0.0001Volume200,000 shsAverage Volume101,150 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Redpoint Bio (OTCMKTS: RPBC) is a development‐stage biopharmaceutical company focused on advancing novel immuno‐oncology therapies. The firm’s primary business activity centers on leveraging the human immune system to create targeted treatments designed to improve outcomes for cancer patients. Redpoint Bio’s research and development efforts employ proprietary technology platforms aimed at modulating the tumor microenvironment to enhance anti‐tumor immune responses. Its pipeline comprises multiple product candidates across discovery and early clinical development stages, each engineered to address unmet needs in oncology. Based in the United States, Redpoint Bio partners with academic institutions and industry collaborators to accelerate the progression of its drug candidates. Publicly available information on the company’s history, leadership team and specific program details remains limited.AI Generated. May Contain Errors. Read More Receive RPBC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Redpoint Bio and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RPBC Stock News HeadlinesCheapest Car Insurance TexasMarch 12, 2024 | marketwatch.comCheapest Car Insurance in Texas for February 2024February 25, 2024 | fool.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.September 17 at 2:00 AM | Brownstone Research (Ad)The Best Texas Car Insurance for 2024January 14, 2024 | fool.comSee More Headlines RPBC Stock Analysis - Frequently Asked Questions How have RPBC shares performed this year? Redpoint Bio's stock was trading at $0.0001 at the beginning of 2025. Since then, RPBC stock has increased by 0.0% and is now trading at $0.0001. How do I buy shares of Redpoint Bio? Shares of RPBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Redpoint Bio own? Based on aggregate information from My MarketBeat watchlists, some other companies that Redpoint Bio investors own include Twitter (TWTR), Towne Bank (TOWN), Hershey (HSY), Ferro (FOE) and BMC Stock (BMCH). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Commercial Physical Research Sub-IndustryBusiness Services Current SymbolOTCMKTS:RPBC CIK1328003 Webwww.redpointbio.com Phone215-456-2312FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:RPBC) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Redpoint Bio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Redpoint Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.